Two Experimental Ebola Vaccines Pass Safety Test in African Trial

Reuters – Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said on Thursday.

http://af.reuters.com/article/liberiaNews/idAFL2N0WS2WN20150326

More from The Black Report®